Sodelglitazar Uses, Dosage, Side Effects and more
Sodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes).
| Trade Name | Sodelglitazar |
| Generic | Sodelglitazar |
| Sodelglitazar Other Names | Sodelglitazar |
| Type | |
| Formula | C23H21F4NO3S2 |
| Weight | Average: 499.54 Monoisotopic: 499.08989854 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
